Gerresheimer has celebrated the start of construction of the plant expansion at its facility in Querétaro, Mexico, with a ground-breaking ceremony. The new 7,500m² production building will increase the annual manufacturing capacity for “ready-to-fill” syringes for the North American market by several hundred million and create around 270 new jobs. Among other things, the high-quality pre-fillable glass syringes are suitable for injectable biopharmaceuticals such as GLP-1-based drugs for the treatment of obesity.

Gerresheimer is investing around €100 million in the new building and the new production lines. The building is expected to be completed by mid-2024 and production is anticipated to start in the second quarter of 2025.

“Our plant in Querétaro will enable us to supply the entire North American trading area with high-quality syringes that are also suitable for biopharmaceuticals”, says Dietmar Siemssen, CEO of Gerresheimer AG. “Now we are once again significantly expanding production capacity for contracts we have already concluded.”

www.gerresheimer.com